Received: 7 January 2022
Accepted: 8 August 2022
First Online: 29 August 2022
: The research protocol (including the experimental protocol) was validated by the Committee for the Protection of Persons (CPP, no. 2017-A02782-51), the French ethical committee for biomedical research, and complied with MR001 reference methodology (agreement from the National Commission for Informatics and Freedoms of 25 September 2018, no. 918233). Information on the survey objectives and consent forms were read with the participants. A written informed consent was obtained from all participants, or if participants were under 15, from a parent and/or legal guardian, who gave their written consent. All methods were carried out in accordance with relevant guidelines and the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.